author-photo

S Debska

11

Papers

15

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Immunohistochemical (IHC) prediction of lapatinib efficacy in HER2-positive advanced breast cancer patients.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: The role of Rad51

2013 The Breast
Show All
- Source
- Cite
- Save
Citations (13)
Abstract P2-10-31: Correlation of quantitative p95HER2 and total HER2 levels with clinical outcomes in a combined analysis of two cohorts of trastuzumab-treated metastatic breast cancer patients

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Gene expression combined with gene set enrichment analysis to identify markers of vinorelbine efficacy in breast cancer patients.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P3-13-03: Molecular factors associated with bone metastases in breast cancer patients

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P3-12-09: The risk of brain metastases according to expression of selected immunohistochemical markers in primary breast cancers

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Thymidilate synthase gene copy number as predictive marker of capecitabine efficacy in patients with breast cancer.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P5-01-06: Gene Copy Number and Expression of TYMP and TYMS Are Predictive of Outcome in Breast Cancer Patients Treated with Capecitabine.

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
P2-12-05: Correlation between Quantitative HER2 Protein Expression and Risk of Brain Metastases in HER2−Positive Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy.

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)